| Literature DB >> 24374377 |
Souvik Karmakar1, Weidong Zhang1, Gul Ahmad2, Mayeen U Alam1, Richard Winn1, Workineh Torben3, Loc Le1, Kory A Tillery1, Afzal A Siddiqui4.
Abstract
Sm-p80, the large subunit of Schistosoma masoni calpain, is a leading antigen candidate for a schistosome vaccine. Prophylactic and antifecundity efficacy of Sm-p80 has been tested using a variety of vaccine approaches. However, the mechanism of Sm-p80-mediated killing is still unknown. In this study, potential role of complement in Sm-p80-mediated protection was studied using both in vitro (cobra venom factor inhibition) and in vivo using mice deficient in C3 (C3 -/-; B6.129S4-C3tm1Crr/J). In the absence of C3, Sm-p80-based vaccine was able to provide significant reduction in adult worm burden following challenge with schistosome cercariae in mice suggesting the effector functions of complement may be limited in this vaccine-induced protection.Entities:
Keywords: Schistosoma; Sm-p80; calpain; complement; schistosomiasis; vaccine
Mesh:
Substances:
Year: 2013 PMID: 24374377 PMCID: PMC4130258 DOI: 10.4161/hv.27576
Source DB: PubMed Journal: Hum Vaccin Immunother ISSN: 2164-5515 Impact factor: 3.452